secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2022-12-27T23:59:59+00:00
Accession:  0001193125-22-311947
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

First Light Acquisition Group co-CEO Bill Weber resigns; Thomas Vecchiolla becomes sole CEO and Chairman
--------------------------------------------------------------------------------

- Bill Weber resigned as co-CEO, Director, and Chairman effective Dec 21, 2022; no disagreement cited.
- Thomas A. Vecchiolla appointed sole CEO and Chairman, effective Dec 22, 2022.
- Weber's departure reduces leadership to a single CEO structure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000119312522311947/0001193125-22-311947-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000119312522311947/d421264d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-311947

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer